Kyverna Therapeutics, Inc.

KYTX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$34,164$53,440$56,865$96,621
Short-Term Investments$136,974$158,237$185,784$189,358
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,787$2,650$5,002$4,622
Total Curr. Assets$174,925$214,327$247,651$290,601
Property Plant & Equip (Net)$6,322$7,577$8,803$10,656
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$551$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$5,358$4,604$4,201$5,263
Total NC Assets$12,231$12,181$13,004$15,919
Other Assets$0$0$0-$1,875
Total Assets$187,156$226,508$260,655$304,645
Liabilities
Payables$3,016$9,917$8,472$4,624
Short-Term Debt$3,685$3,576$3,585$3,940
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$27,170$26,296$21,235$25,192
Total Curr. Liab.$33,871$39,789$33,292$33,756
LT Debt$1,339$2,342$3,353$4,302
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,339$2,342$3,353$4,302
Other Liabilities$0$0$0$0
Cap. Leases$1,339$5,918$6,938$8,242
Total Liabilities$35,210$42,131$36,645$38,058
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$387,023-$350,236-$308,155-$263,520
AOCI$29-$20-$1$105
Other Equity$538,940$534,633$532,166$530,002
Total Equity$151,946$184,377$224,010$266,587
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$187,156$226,508$260,655$304,645
Net Debt-$29,140-$47,522-$49,927-$88,379
Kyverna Therapeutics, Inc. (KYTX) Financial Statements & Key Stats | AlphaPilot